23andMe Looking at Hereditary Colorectal Cancer Syndrome
The Mountain View, CA-based company received a nod from FDA for the MUTYH-Associated Polyposis Genetic Health Risk report.
IVD
New Blood Test Determines Likelihood of Lung Transplant Rejection
The donor-derived cell-free DNA test was developed by the National Institutes of Health/National Heart Blood and Lung Institute.
A Newly Developed Nanosensor Quickly Detects Disease
The test, developed by Researchers at the Institute for Global Food Security at Queen’s University Belfast, can detect proteases, enzyme markers that are responsible for the progression of many diseases.
New Data Boosts Value Proposition of AlloSure
The first donor-derived cell-free DNA test to assess allograft health in kidney transplant patients is also beneficial for repeat transplant recipients, a new study finds.
Antibiotic-Resistance-Screening Diagnostic Wins CE Mark
The new test could help clinicians quickly determine the appropriate treatment for patients.
ArcherDx Seeking Broader Reach for Cancer Diagnostic
The Boulder, CO-based company has been granted a Breakthrough Device Designation for its liquid biopsy and tissue specimen assay.
Noninvasive Test for Colon Cancer Screening Offered as an Alternative to Colonoscopy for Screening
CellMax Life has developed a blood test that it says can identify precancerous adenomas with similar accuracy as colonoscopy, which may facilitate better compliance with screenings and increase detection rates.
New Study Finds Discrepancies in Cervical Cancer Screening Rates
A study from Mayo Clinic researchers shows less than two thirds of women ages 30 to 65 were up-to-date with cervical cancer screenings in 2016, which is below the 81% screening compliance rate self-reported in the 2015 National Health Interview Survey.
Veracyte Finds Ally in J&J for Early Lung Cancer Detection
The two companies will look at advancing the development and commercialization of diagnostic tests for early detection of the disease.
How a Tiny Device Is Making a Big Difference for Pediatric Transplant Patients
An initiative at Nottingham University Hospital in Nottingham, England is making it easier for pediatric transplant patients and their caregivers to collect blood samples at home for therapeutic drug monitoring.
New Field Test Discerns Between Ebola and Lookalike Fevers
The portable device could prove to be invaluable during an Ebola outbreak.
Investigators on the Path to Alzheimer’s Detection Test
A team from Brigham and Women’s Hospital are developing a test that can detect tau protein, a calling card for Alzheimer’s disease.
GRAIL’s SUMMIT Will Help Define its Liquid Biopsy Path
The Menlo Park, CA-based company’s 50,000-patient trial will launch in 2019 and could be one of the most significant events of the year for the liquid biopsy market.
How a New Blood Volume Analyzer Could Save Lives From Acute Heart Failure
Daxor’s new technology designed to measure blood volume has the potential to reduce patient readmission rates and improve outcomes for patients suffering from acute heart failure.
Diagnostics Are Helping Counter Antimicrobial Resistance, But More Work Is Needed
Doctors need more tools to quickly determine whether an antibiotic is truly needed, an expert tells MD+DI.
Oxford Startup Wants to Revolutionize Sensors
A startup spawned from Oxford University is trying to commercialize components of a quantum computing technology that could ultimately improve the downstream end of existing diagnostic devices.